Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,448 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Trabecular Bone Score as a Complementary Tool for the Assessment of Bone Mineral Density in Patients with Asymptomatic Monoclonal Gammopathies.
Drakoulidou S, Ntanasis-Stathopoulos I, Kyritsi A, Koutoulidis V, Malandrakis P, Kanellias N, Kastritis E, Dimopoulos MA, Gavriatopoulou M, Chalazonitis A, Terpos E. Drakoulidou S, et al. Among authors: dimopoulos ma. J Clin Med. 2024 Oct 28;13(21):6461. doi: 10.3390/jcm13216461. J Clin Med. 2024. PMID: 39518598 Free PMC article.
Siltuximab in Idiopathic Multicentric Castleman Disease: Real-World Experience.
Jitaru C, Symeonidis A, Badelita S, Katodritou E, Colita A, Mpanti A, Bancos A, Tigu B, Rotariu P, Urian L, Rus I, Dima D, Bojan A, Damian M, Labropoulou V, Muresan MS, Fotiou D, Fetica B, Petrushev B, Dascalescu A, Dalampira D, Buruiana S, Constantinescu C, Zdrenghea M, Dimopoulos MA, Tomuleasa C, Terpos E. Jitaru C, et al. Among authors: dimopoulos ma. J Hematol. 2024 Oct;13(5):207-215. doi: 10.14740/jh1343. Epub 2024 Oct 21. J Hematol. 2024. PMID: 39493599 Free PMC article.
Phase 1 first-in-human study of MEDI2228, a BCMA-targeted ADC, in patients with relapsed refractory multiple myeloma.
Dimopoulos MA, Migkou M, Bhutani M, Ailawadhi S, Kalff A, Walcott FL, Pore N, Brown M, Wang F, Cheng LI, Kagiampakis I, Williams M, Kinneer K, Wu Y, Jiang Y, Kubiak RJ, Zonder JA, Larsen J, Sirdesai S, Yee AJ, Kumar S. Dimopoulos MA, et al. Leuk Lymphoma. 2024 Oct 15:1-12. doi: 10.1080/10428194.2024.2373331. Online ahead of print. Leuk Lymphoma. 2024. PMID: 39404476
VCd versus VRd in Newly Diagnosed Multiple Myeloma: Matched Real-World Analysis from the Balkan Myeloma Study Group (BMSG).
Kastritis E, Beksac M, Badelita SN, Katodritou E, Bila J, Spanoudakis E, Seval GC, Cvetkovic Z, Markovic O, Toprak SK, Dalampira D, Coriu D, Bezirgiannidou Z, Pirsic M, Valkovic T, Ursuleac I, Sretenovic A, Sevastoudi A, Batinic J, Barbu S, Roussou M, Gavriatopoulou M, Terpos E, Dimopoulos MA; Balkan Myeloma Study Group. Kastritis E, et al. Among authors: dimopoulos ma. Clin Lymphoma Myeloma Leuk. 2024 Aug 21:S2152-2650(24)00312-4. doi: 10.1016/j.clml.2024.08.007. Online ahead of print. Clin Lymphoma Myeloma Leuk. 2024. PMID: 39304364
A plain language summary of the PERSEUS study of daratumumab plus bortezomib, lenalidomide, and dexamethasone for treating newly diagnosed multiple myeloma.
Sonneveld P, Dimopoulos MA, Boccadoro M, Quach H, Ho PJ, Beksac M, Hulin C, Antonioli E, Leleu X, Mangiacavalli S, Perrot A, Cavo M, Belotti A, Broijl A, Gay F, Mina R, van de Donk NWCJ, Katodritou E, Schjesvold F, Balari AS, Rosiñol L, Delforge M, Roeloffzen W, Silzle T, Vangsted A, Einsele H, Spencer A, Hajek R, Jurczyszyn A, Lonergan S, Ahmadi T, Liu Y, Wang J, Vieyra D, van Brummelen EMJ, Vanquickelberghe V, Sitthi-Amorn A, de Boer CJ, Carson R, Rodriguez-Otero P, Bladé J, Moreau P. Sonneveld P, et al. Among authors: dimopoulos ma. Future Oncol. 2024 Sep 17:1-21. doi: 10.1080/14796694.2024.2394323. Online ahead of print. Future Oncol. 2024. PMID: 39287147
1,448 results